Skip to main content
. 2017 May 10;27(5):439–447. doi: 10.1097/CMR.0000000000000367

Fig. 2.

Fig. 2

Responses and survival after 131 procedures in 27 patients. Each T column shows a separate treatment; each row corresponds to the outcomes of each patient following the treatments. AWD, alive without disease; D, distant site of progression; % M-MGMT, percentage of MGMT promoter methylation; P, pelvic site of progression; T, treatment.